SNP GENOTYPING AND ANALYSIS MARKET ANALYSIS

SNP Genotyping and Analysis Market, By Technology (Polymerase Chain Reaction (PCR), Microarray, Next-Generation Sequencing (NGS), Taqman Allelic Discrimination, Pyrosequencing, and Others), By Applications (Diagnostics & Forensics, Pharmacogenomics, Agricultural Biotechnology, and Breeding & Animal Livestock), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Published In : Jul 2023
Code : CMI3972
Pages :156
Formats :
Excel and PDF
Industry : Biotechnology

Regional Analysis

Global SNP Genotyping And Analysis Market- Regional Analysis

Among region, North America is estimated to hold a dominant position in the global SNP genotyping and analysis market over the forecast period. North America holds 35.2% of the market share, attributed to the increading burdern of chronic disorder. Genotyping techniques can be utilized for early diagnosis and treatment of chronic diseases. According to the 2022 report from the National Association of Chronic Disease Directors, about 60% of adult Americans have at least one chronic disease. Diabetes, cancer, and cardiovascular disease are among the top causes of death in the United States. One or more of the following five chronic diseases account for more than two-thirds of all deaths: heart disease, cancer, stroke, chronic obstructive pulmonary disease, and diabetes. According to the CDC, people with chronic diseases and mental health disorders account for 90% of the nation's US$ 3.8 trillion in annual healthcare costs.

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa